Leśniewski-Kmak Krzysztof - Gdynia Oncology Centre, Medical University of Gdansk

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 68 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract PD1-04: Results of a Phase II Double-Blinded, Randomized, Placebo-Controlled Clinical Trial of Indoximod, an Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor, in Combination with Taxane Chemotherapy in Metastatic Breast Cancer (MBC)

Veronica Mariotti,Shou-Ching Tang,Patrick Dillon,Alberto Montero,Andrew Poklepovic,Susan Melin,Ibrahim Nuhad,Petros Nikolinakos,Eugene Kennedy,Hyo Han,Roohi Ismail-Khan,Daniel Bruetman,Oana Danciu,Paul Gilman,Boguslawa Karaszewska,Krzysztof Lesniewski-Kmak,Timothy Panella, Dhimant Patel, Malgorzata Suszko-Kazarnowicz,Fabio Volterra,Hatem Soliman

Cancer Researchno. 4_Supplement (2020): PD1-04

Cited1Views0Bibtex

67P Survival of Responders to Nivolumab (NIVO) + Ipilimumab (IPI) As First-Line Treatment for Advanced NSCLC in CheckMate 227, Part 1

J. R. Brahmer,T-E. Ciuleanu,M. Schenker,C. Audigier-Valette,B. Zurawski,H. Linardou,S-W. Kim,G. A. Otterson,P. Salman,E. De La Mora Jimenez,K. Lesniewski-Kmak, S. Ahmed,I. Albert,F. Barlesi, K. Feeney,N. Frickhofen,A. Li, P. Sun,M. Hellmann

Annals of oncology（2020）

Cited3Views0Bibtex

MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study

Tamas Hickish,Thierry André,Lucjan Wyrwicz,Mark P Saunders,Tomasz Sarosiek,Judit Kocsis,Radim Nemecek,Wojciech Rogowski,Krzysztof Lesniewski-Kmak,Lubos Petruzelka,Ron N. Apte,Prasant Mohanty,Michael Stecher,John Simard,Aimery de Gramont

The Lancet Oncologyno. 2 (2017): 192-201

Cited131Views0WOSBibtex

131

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn